Healthcare provider profile · identity verified

Robert Byrne, M.D.

Internal Medicine · BRIDGETON, MO · NPI 1124009022

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	939	257
Losartan Potassium	Losartan Potassium	528	154
Metoprolol Succinate	Metoprolol Succinate	489	137
Furosemide	Furosemide	478	139
Amlodipine Besylate	Amlodipine Besylate	463	141
Levothyroxine Sodium	Levothyroxine Sodium	398	109
Pantoprazole Sodium	Pantoprazole Sodium	315	99
Rosuvastatin Calcium	Rosuvastatin Calcium	301	95
Lisinopril	Lisinopril	292	80
Methylprednisolone	Methylprednisolone	244	130
Hydrochlorothiazide	Hydrochlorothiazide	243	71
Metoprolol Tartrate	Metoprolol Tartrate	237	59
Eliquis	Apixaban	220	49
Mirtazapine	Mirtazapine	217	66
Albuterol Sulfate Hfa	Albuterol Sulfate	205	57
Metformin Hcl Er	Metformin Hcl	205	63
Omeprazole	Omeprazole	200	61
Gabapentin	Gabapentin	192	57
Simvastatin	Simvastatin	191	47
Alprazolam	Alprazolam	190	44
Metformin Hcl	Metformin Hcl	189	65
Fluticasone Propionate	Fluticasone Propionate	178	65
Alendronate Sodium	Alendronate Sodium	173	48
Hydralazine Hcl	Hydralazine Hcl	170	47
Allopurinol	Allopurinol	156	40
Potassium Chloride	Potassium Chloride	151	43
Doxycycline Hyclate	Doxycycline Hyclate	149	72
Glipizide	Glipizide	146	36
Carvedilol	Carvedilol	145	41
Tamsulosin Hcl	Tamsulosin Hcl	133	38
Diclofenac Sodium	Diclofenac Sodium	114	35
Trazodone Hcl	Trazodone Hcl	114	34
Clopidogrel	Clopidogrel Bisulfate	113	34
Famotidine	Famotidine	107	40
Ozempic	Semaglutide	106	20
Escitalopram Oxalate	Escitalopram Oxalate	98	29
Buspirone Hcl	Buspirone Hcl	91	26
Jardiance	Empagliflozin	90	21
Lorazepam	Lorazepam	84	24
Pravastatin Sodium	Pravastatin Sodium	84	26
Meloxicam	Meloxicam	82	26
Wixela Inhub	Fluticasone Propion/Salmeterol	76	27
Citalopram Hbr	Citalopram Hydrobromide	75	21
Spironolactone	Spironolactone	73	21
Terazosin Hcl	Terazosin Hcl	72	24
Tizanidine Hcl	Tizanidine Hcl	72	29
Sertraline Hcl	Sertraline Hcl	69	23
Prednisone	Prednisone	65	23
Warfarin Sodium	Warfarin Sodium	64	12
Glipizide Er	Glipizide	63	19
Lovastatin	Lovastatin	58	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	58	35
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	17
Ropinirole Hcl	Ropinirole Hcl	57	19
Venlafaxine Hcl Er	Venlafaxine Hcl	53	14
Torsemide	Torsemide	51	20
Tramadol Hcl	Tramadol Hcl	50	11
Atenolol	Atenolol	49	12
Donepezil Hcl	Donepezil Hcl	48	14
Amoxicillin	Amoxicillin	46	34
Ketoconazole	Ketoconazole	45	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	14
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Ondansetron Hcl	Ondansetron Hcl	43	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	34
Fluoxetine Hcl	Fluoxetine Hcl	40	13
Combivent Respimat	Ipratropium/Albuterol Sulfate	39	15
Tolterodine Tartrate Er	Tolterodine Tartrate	39	12
Ipratropium Bromide	Ipratropium Bromide	38	11
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	13
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	33	suppressed
Acarbose	Acarbose	32	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Ibuprofen	Ibuprofen	32	suppressed
Nystatin	Nystatin	32	16
Zolpidem Tartrate	Zolpidem Tartrate	31	11
Montelukast Sodium	Montelukast Sodium	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Azithromycin	Azithromycin	26	19
Glimepiride	Glimepiride	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	12
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Galantamine Er	Galantamine Hbr	24	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	23	23
Bupropion Xl	Bupropion Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Primidone	Primidone	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Naproxen	Naproxen	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Benzonatate	Benzonatate	17	17
Klor-Con M20	Potassium Chloride	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Chlorthalidone	Chlorthalidone	16	suppressed
Leflunomide	Leflunomide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Nadolol	Nadolol	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Cefdinir	Cefdinir	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error